需要进行病毒控制,以便在被类免疫缺陷病毒感染的中进行静脉BCG介导的防治结核病
Research square
|January 9, 2026
概括
静脉注射Bacillus Calmette-Guérin (IV-BCG) 疫苗对SIV+提供了显著的结核病保护,即使使用抗BCG药物治疗. 病毒控制对于最佳的疫苗引起的结核病保护至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
背景情况:
- 结核病 (TB) 仍然是一个全球性的健康威胁,特别是在艾滋病毒感染者 (PLWH) 中.
- 之前的研究表明,静脉注射Bacillus Calmette-Guérin (IV-BCG) 在SIV+毛里求斯Cynomolgus (MCM) 中提供强大的抗结核保护.
研究的目的:
- 评估使用抗结核药物消除BCG是否会影响SIV+MCM中的IV-BCG免疫性和疗效.
- 确定病毒控制在疫苗引起的结核病保护中的作用.
主要方法:
- 在接种疫苗后1或3周,SIV+接种了IV-BCG接种疫苗,随后接种了抗BCG药物治疗方案 (伊索尼亚,里芬素,乙胺醇).
- 在接种疫苗后的5个月内,受到Mycobacterium tuberculosis (Mtb) 的挑战,并在接种疫苗后的12周内进行监测.
主要成果:
- 无论抗BCG药物治疗的时间,IV-BCG都能提供显著的保护.
- 与控制者相比,高病毒血量和低肺CD4+T细胞的非对照者显示出较低的保护.
- 即使在接种疫苗后不久消除了细菌,BCG疗效也保持不变.
结论:
- 尽管接受了抗BCG药物治疗,IV-BCG在SIV+MCM中的强大疗效仍然保持不变,这表明BCG不需要长时间的生存才能获得保护.
- 病毒控制对于在PLWH中实现疫苗引起的完全防治结核病至关重要.
更多相关视频
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.2K
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.9K
相关概念视频
Pulmonary Tuberculosis IV
472
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
472
Pulmonary Tuberculosis V
532
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
532
Pulmonary Tuberculosis I
820
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
820
